English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  51735161    線上人數 :  2053
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"liang s k"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 96-105 / 137 (共14頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2020-05-26T09:26:19Z Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations Ko J.-C; CHIH-HSIN YANG; Shih J.-Y.; Liang S.-K; Liang S.-K;Ko J.-C;Chih-Hsin Yang;Shih J.-Y.
臺大學術典藏 2020-03-31T08:54:35Z Otitis media and otomastoiditis caused by Mycobacterium massiliense (Mycobacterium abscessus subsp. bolletii) Lee M.-R.; Tsai H.-Y.; Cheng A.; Liu C.-Y.; Huang Y.-T.; Liao C.-H.; Liang S.-K.; LI-NA LEE; Hsueh P.-R.
臺大學術典藏 2020-03-31T08:54:33Z Evaluating pleural ADA, ADA2, IFN-γ and IGRA for diagnosing tuberculous pleurisy Wang J.-Y.; Yu C.-J.; LI-NA LEE; Keng L.-T.; Shu C.-C.; Chang C.-H.; Chang L.-Y.; Liang S.-K.; Lin C.-K.; Chen J.Y.P.
臺大學術典藏 2020-03-27T05:29:16Z Otitis media and otomastoiditis caused by Mycobacterium massiliense (Mycobacterium abscessus subsp. bolletii) Lee L.-N.; PO-REN HSUEH; Liang S.-K.; Liao C.-H.; Huang Y.-T.; Liu C.-Y.; Cheng A.; Tsai H.-Y.; Lee M.-R.; PO-REN HSUEH;Lee L.-N.;Liang S.-K.;Liao C.-H.;Huang Y.-T.;Liu C.-Y.;Cheng A.;Tsai H.-Y.;Lee M.-R.
臺大學術典藏 2020-03-27T05:29:02Z Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolates Lee M.-R.; Ko J.-C.; Liang S.-K.; Lee S.-W.; Yen D.H.-T.; PO-REN HSUEH; PO-REN HSUEH;Yen D.H.-T.;Lee S.-W.;Liang S.-K.;Ko J.-C.;Lee M.-R.
臺大學術典藏 2020-03-27T05:28:53Z Clinical characteristics of bacteraemia caused by Lactobacillus spp. and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2000-2014 PO-REN HSUEH;Huang Y.-T.;Lin C.-K.;Liang S.-K.;Tsai C.-J.;Lee M.-R.; Lee M.-R.; Tsai C.-J.; Liang S.-K.; Lin C.-K.; Huang Y.-T.; PO-REN HSUEH
臺大學術典藏 2020-03-05T08:04:03Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang S.-K.;Min-Shu Hsieh;Lee M.-R.;Keng L.-T.;Ko J.-C.;Shih J.-Y.; Liang S.-K.; MIN-SHU HSIEH; Lee M.-R.; Keng L.-T.; Ko J.-C.; Shih J.-Y.
國立成功大學 2020 Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model Chien, L.-H.;Chen, Chen C.-H.;Chen, T.-Y.;Chang, G.-C.;Tsai, Y.-H.;Hsiao, C.-F.;Chen, K.-Y.;Su, W.-C.;Wang, Wang W.-C.;Huang, M.-S.;Chen, Y.-M.;Chen, Chen C.-Y.;Liang, S.-K.;Chen, Chen C.-Y.;Wang, C.-L.;Lee, M.-H.;Chung, R.-H.;Tsai, F.-Y.;Hu, J.-W.;Katki, H.A.;Chatterjee, N.;Chanock, S.J.;Rothman, N.;Lan, Q.;Yang, P.-C.;Chen, Chen C.-J.;Chang, I.-S.;Hsiung, C.A.
臺大學術典藏 2018 Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study Liao W.-Y.; MENG-RUI LEE; Liang S.-K.; Ho C.-C.; Ko J.-C.; Shih J.-Y.
臺大學術典藏 2017 Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang S.-K.; Hsieh M.-S.; MENG-RUI LEE; Keng L.-T.; Ko J.-C.; Shih J.-Y.

顯示項目 96-105 / 137 (共14頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目